Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ann Moen is active.

Publication


Featured researches published by Ann Moen.


The Journal of Infectious Diseases | 2012

Influenza Surveillance in 15 Countries in Africa, 2006-2010

Jennifer Michalove Radin; Mark A. Katz; Stefano Tempia; Ndahwouh Talla Nzussouo; Richard Davis; Jazmin Duque; Adebayo Adedeji; Michael Adjabeng; William Ampofo; Workenesh Ayele; Barnabas Bakamutumaho; Amal Barakat; Adam L. Cohen; Cheryl Cohen; Ibrahim Dalhatu; Coulibaly Daouda; Erica Dueger; Moisés Francisco; Jean-Michel Heraud; Daddi Jima; Alice Kabanda; Hervé Kadjo; Amr Kandeel; Stomy Karhemere Bi Shamamba; Francis Kasolo; Karl C. Kronmann; Mazyanga Liwewe; Julius Julian Lutwama; Miriam Matonya; Vida Mmbaga

BACKGROUND In response to the potential threat of an influenza pandemic, several international institutions and governments, in partnership with African countries, invested in the development of epidemiologic and laboratory influenza surveillance capacity in Africa and the African Network of Influenza Surveillance and Epidemiology (ANISE) was formed. METHODS We used a standardized form to collect information on influenza surveillance system characteristics, the number and percent of influenza-positive patients with influenza-like illness (ILI), or severe acute respiratory infection (SARI) and virologic data from countries participating in ANISE. RESULTS Between 2006 and 2010, the number of ILI and SARI sites in 15 African countries increased from 21 to 127 and from 2 to 98, respectively. Children 0-4 years accounted for 48% of all ILI and SARI cases of which 22% and 10%, respectively, were positive for influenza. Influenza peaks were generally discernible in North and South Africa. Substantial cocirculation of influenza A and B occurred most years. CONCLUSIONS Influenza is a major cause of respiratory illness in Africa, especially in children. Further strengthening influenza surveillance, along with conducting special studies on influenza burden, cost of illness, and role of other respiratory pathogens will help detect novel influenza viruses and inform and develop targeted influenza prevention policy decisions in the region.


Bulletin of The World Health Organization | 2014

Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia

Siddhartha Saha; Mandeep S. Chadha; Abdullah Al Mamun; Mahmudur Rahman; Katharine Sturm-Ramirez; Malinee Chittaganpitch; Sirima Pattamadilok; Sonja J. Olsen; Ondri Dwi Sampurno; Vivi Setiawaty; Krisna Nur Andriana Pangesti; Gina Samaan; Sibounhom Archkhawongs; Phengta Vongphrachanh; Darouny Phonekeo; Andrew Corwin; Sok Touch; Philippe Buchy; Nora Chea; Paul Kitsutani; Le Quynh Mai; Vu Dinh Thiem; Raymond T. P. Lin; Constance Low; Chong Chee Kheong; Norizah Ismail; Mohd Apandi Yusof; Amado Tandoc; Vito G. Roque; Akhilesh C. Mishra

OBJECTIVE To characterize influenza seasonality and identify the best time of the year for vaccination against influenza in tropical and subtropical countries of southern and south-eastern Asia that lie north of the equator. METHODS Weekly influenza surveillance data for 2006 to 2011 were obtained from Bangladesh, Cambodia, India, Indonesia, the Lao Peoples Democratic Republic, Malaysia, the Philippines, Singapore, Thailand and Viet Nam. Weekly rates of influenza activity were based on the percentage of all nasopharyngeal samples collected during the year that tested positive for influenza virus or viral nucleic acid on any given week. Monthly positivity rates were then calculated to define annual peaks of influenza activity in each country and across countries. FINDINGS Influenza activity peaked between June/July and October in seven countries, three of which showed a second peak in December to February. Countries closer to the equator had year-round circulation without discrete peaks. Viral types and subtypes varied from year to year but not across countries in a given year. The cumulative proportion of specimens that tested positive from June to November was > 60% in Bangladesh, Cambodia, India, the Lao Peoples Democratic Republic, the Philippines, Thailand and Viet Nam. Thus, these tropical and subtropical countries exhibited earlier influenza activity peaks than temperate climate countries north of the equator. CONCLUSION Most southern and south-eastern Asian countries lying north of the equator should consider vaccinating against influenza from April to June; countries near the equator without a distinct peak in influenza activity can base vaccination timing on local factors.


Influenza and Other Respiratory Viruses | 2012

Multisite virological influenza surveillance in India: 2004-2008.

Mandeep S. Chadha; Shobha Broor; Palani Gunasekaran; Varsha A. Potdar; Anand Krishnan; Mamta Chawla-Sarkar; Dipankar Biswas; Asha Mary Abraham; Sv Jalgaonkar; Harpreet Kaur; Alexander Klimov; Renu B. Lal; Ann Moen; Lalit Kant; Akhilesh C. Mishra

Please cite this paper as: Chadha et al. (2011) Multi site Virological Influenza Surveillance in India: 2004–2008. Influenza and Other Respiratory Viruses 6(3), 196–203.


PLOS ONE | 2012

Dynamic Patterns of Circulating Seasonal and Pandemic A(H1N1)pdm09 Influenza Viruses From 2007–2010 in and around Delhi, India

Shobha Broor; Anand Krishnan; Dipanjan S. Roy; Shivram Dhakad; Samander Kaushik; Muneer A. Mir; Yashpal Singh; Ann Moen; Mandeep S. Chadha; Akhilesh C. Mishra; Renu B. Lal

Influenza surveillance was carried out in a subset of patients with influenza-like illness (ILI) presenting at an Employee Health Clinic (EHS) at All India Institute of Medical Sciences (AIIMS), New Delhi (urban) and pediatric out patients department of civil hospital at Ballabhgarh (peri-urban), under the Comprehensive Rural Health Services Project (CRHSP) of AIIMS, in Delhi region from January 2007 to December 2010. Of the 3264 samples tested, 541 (17%) were positive for influenza viruses, of which 221 (41%) were pandemic Influenza A(H1N1)pdm09, 168 (31%) were seasonal influenza A, and 152 (28%) were influenza B. While the Influenza viruses were detected year-round, their types/subtypes varied remarkably. While there was an equal distribution of seasonal A(H1N1) and influenza B in 2007, predominance of influenza B was observed in 2008. At the beginning of 2009, circulation of influenza A(H3N2) viruses was observed, followed later by emergence of Influenza A(H1N1)pdm09 with co-circulation of influenza B viruses. Influenza B was dominant subtype in early 2010, with second wave of Influenza A(H1N1)pdm09 in August-September, 2010. With the exception of pandemic H1N1 emergence in 2009, the peaks of influenza activity coincided primarily with monsoon season, followed by minor peak in winter at both urban and rural sites. Age group analysis of influenza positivity revealed that the percent positivity of Influenza A(H1N1)pdm09 influenza virus was highest in >5–18 years age groups (OR 2.5; CI = 1.2–5.0; p = 0.009) when compared to seasonal influenza. Phylogenetic analysis of Influenza A(H1N1)pdm09 from urban and rural sites did not reveal any major divergence from other Indian strains or viruses circulating worldwide. Continued surveillance globally will help define regional differences in influenza seasonality, as well as, to determine optimal periods to implement influenza vaccination programs among priority populations.


The Journal of Infectious Diseases | 2012

Delayed 2009 Pandemic Influenza A Virus Subtype H1N1 Circulation in West Africa, May 2009–April 2010

Ndahwouh Talla Nzussouo; Jennifer Michalove; Ousmane M. Diop; Richard Njouom; Maria de Lourdes Monteiro; Herve Kadjo Adje; Serge Manoncourt; Joseph Amankwa; Lamine Koivogui; Samba O. Sow; Mohamed Brahim Elkory; Jean-Marc Collard; Ibrahim Dalhatu; Mbayame Ndiaye Niang; Kathryn E. Lafond; Filomena Moniz; Daouda Coulibaly; Karl C. Kronman; Buhari Oyofo; William Ampofo; Boubou Tamboura; Ahmed Ould Bara; Jean-François Jusot; Ekanem Ekanem; Fatoumata Diene Sarr; Inzune Hwang; Claire Cornelius; Babajide Coker; Stephen Lindstrom; Richard Davis

To understand 2009 pandemic influenza A virus subtype H1N1 (A[H1N1]pdm09) circulation in West Africa, we collected influenza surveillance data from ministries of health and influenza laboratories in 10 countries, including Cameroon, from 4 May 2009 through 3 April 2010. A total of 10,203 respiratory specimens were tested, of which 25% were positive for influenza virus. Until the end of December 2009, only 14% of all detected strains were A(H1N1)pdm09, but the frequency increased to 89% from January through 3 April 2010. Five West African countries did not report their first A(H1N1)pdm09 case until 6 months after the emergence of the pandemic in North America, in April 2009. The time from first detection of A(H1N1)pdm09 in a country to the time of A(H1N1)pdm09 predominance varied from 0 to 37 weeks. Seven countries did not report A(H1N1)pdm09 predominance until 2010. Introduction and transmission of A(H1N1)pdm09 were delayed in this region.


Bulletin of The World Health Organization | 2012

Population-based active surveillance cohort studies for influenza: lessons from Peru

Hugo Razuri; Candice Romero; Yeny O. Tinoco; Maria Claudia Guezala; Ernesto Ortiz; Maria Silva; Erik J. Reaves; Maya Williams; Victor Alberto Laguna-Torres; Eric S. Halsey; Jorge Gomez; Eduardo Azziz-Baumgartner; Marc-Alain Widdowson; Joe S. Bresee; Ann Moen; Timothy M. Uyeki; Andrew J. Bennett; Joel M. Montgomery; Daniel G. Bausch

Disease surveillance, essential for guid -ing the public health response to influ-enza and other respiratory diseases, al-lows for early case detection and for the implementation of preventive measures. The World Health Organization (WHO) recommends passive health-provider based surveillance, or “sentinel surveil -lance”, for influenza-like illness (ILI)


Clinical Infectious Diseases | 2016

The Effect of Influenza Vaccination on Birth Outcomes in a Cohort of Pregnant Women in Lao PDR, 2014–2015

Sonja J. Olsen; Sara Mirza; Phouvanh Vonglokham; Viengphone Khanthamaly; Bounlap Chitry; Vathsana Pholsena; Visith Chitranonh; Saad B. Omer; Ann Moen; Joseph S. Bresee; Andrew Corwin; Anonh Xeuatvongsa

BACKGROUND Some studies suggest that maternal influenza vaccination can improve birth outcomes. However, there are limited data from tropical settings, particularly Southeast Asia. We conducted an observational study in Laos to assess the effect of influenza vaccination in pregnant women on birth outcomes. METHODS We consented and enrolled a cohort of pregnant woman who delivered babies at 3 hospitals during April 2014-February 2015. We collected demographic and clinical information on mother and child. Influenza vaccination status was ascertained by vaccine card. Primary outcomes were the proportion of live births born small for gestational age (SGA) or preterm and mean birth weight. Multivariate models controlled for differences between vaccinated and unvaccinated women and influenza virus circulation. RESULTS We enrolled 5103 women (2172 [43%] were vaccinated). Among the 4854 who had a live birth, vaccinated women were statistically significantly less likely than unvaccinated women to have an infant born preterm during the period of high influenza virus circulation (risk ratio [RR] = 0.56, 95% confidence interval [CI], .45-.70), and the effect remained after adjusting for covariates (adjusted RR, 0.69; 95% CI, .55-.87). There was no effect of vaccine on mean birth weight. Vaccinated mothers had a statistically significant elevated risk of having an infant born SGA (adjusted RR, 1.25; 95% CI, 1.11–1.41). CONCLUSIONS In this observational study, we found indirect evidence of influenza vaccine safety during pregnancy, and women who received vaccine had a reduced risk of delivering a preterm infant during times of high influenza virus circulation. Vaccination may prevent 1 in 5 preterm births that occur during periods of high influenza circulation.


Emerging Infectious Diseases | 2016

Improved Global Capacity for Influenza Surveillance.

Lauren S. Polansky; Sajata Outin-Blenman; Ann Moen

During 2004-2009, the Centers for Disease Control and Prevention (CDC) partnered with 39 national governments to strengthen global influenza surveillance. Using World Health Organization data and program evaluation indicators collected by CDC in 2013, we retrospectively evaluated progress made 4-9 years after the start of influenza surveillance capacity strengthening in the countries. Our results showed substantial increases in laboratory and sentinel surveillance capacities, which are essential for knowing which influenza strains circulate globally, detecting emergence of novel influenza, identifying viruses for vaccine selection, and determining the epidemiology of respiratory illness. Twenty-eight of 35 countries responding to a 2013 questionnaire indicated that they have leveraged routine influenza surveillance platforms to detect other pathogens. This additional surveillance illustrates increased health-system strengthening. Furthermore, 34 countries reported an increased ability to use data in decision making; data-driven decisions are critical for improving local prevention and control of influenza around the world.


Preventive Veterinary Medicine | 2015

Understanding the poultry trade network in Kenya: Implications for regional disease prevention and control

Margaret McCarron; Peninah Munyua; Po-Yung Cheng; Thomas Manga; Cathryn Wanjohi; Ann Moen; Anthony W. Mounts; Mark A. Katz

Infectious diseases in poultry can spread quickly and lead to huge economic losses. In the past decade, on multiple continents, the accelerated spread of highly pathogenic avian Influenza A (H5N1) virus, often through informal trade networks, has led to the death and culling of hundreds of millions of poultry. Endemic poultry diseases like Newcastle disease and fowl typhoid can also be devastating in many parts of the world. Understanding trade networks in unregulated systems can inform policy decisions concerning disease prevention and containment. From June to December 2008 we conducted a cross-sectional survey of backyard farmers, market traders, and middlemen in 5/8 provinces in Kenya. We administered a standardized questionnaire to each type of actor using convenience, random, snowball, and systematic sampling. Questionnaires addressed frequency, volume, and geography of trade, as well as biosecurity practices. We created a network diagram identifying the most important locations for trade. Of 380 respondents, 51% were backyard farmers, 24% were middlemen and 25% were market traders. Half (50%) of backyard farmers said they raised poultry both for household consumption and for sale. Compared to market traders, middlemen bought their poultry from a greater number of villages (median 4.2 villages for middlemen vs. 1.9 for market traders). Traders were most likely to purchase poultry from backyard farmers. Of the backyard farmers who sold poultry, 51% [CI 40-63] reported selling poultry to market traders, and 54% [CI 44-63] sold to middlemen. Middlemen moved the largest volume of poultry on a weekly basis (median purchases: 187 birds/week [IQR 206]; median sales: 188 birds/week [IQR 412.5]). The highest numbers of birds were traded in Nairobi - Kenyas capital city. Nairobi was the most prominent trading node in the network (61 degrees of centrality). Many smaller sub-networks existed as a result of clustered local trade. Market traders were also integral to the network. The informal poultry trade in Kenya is dependent on the sale of backyard poultry to middlemen and market traders. These two actors play a critical role in poultry movement in Kenya; during any type of disease outbreak middlemen should be targeted for control- and containment-related interventions.


Influenza and Other Respiratory Viruses | 2015

Introducing seasonal influenza vaccine in low-income countries: an adverse events following immunization survey in the Lao People's Democratic Republic.

Manilay Phengxay; Sara Mirza; Rita Reyburn; Anonh Xeuatvongsa; C. Winter; Hannah Lewis; Sonja J. Olsen; Reiko Tsuyuoka; Viengphone Khanthamaly; Francisco S. Palomeque; Joseph S. Bresee; Ann Moen; Andrew Corwin

In 2012, Lao PDR introduced seasonal influenza vaccine in pregnant women, persons aged ≥50 years, persons with chronic diseases, and healthcare personnel. We assessed adverse events following immunization (AEFI).

Collaboration


Dive into the Ann Moen's collaboration.

Top Co-Authors

Avatar

Joseph S. Bresee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Andrew Corwin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sara Mirza

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sonja J. Olsen

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Viengphone Khanthamaly

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alba María Ropero

Pan American Health Organization

View shared research outputs
Top Co-Authors

Avatar

Nancy J. Cox

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Akhilesh C. Mishra

National Institute of Virology

View shared research outputs
Top Co-Authors

Avatar

Mandeep S. Chadha

National Institute of Virology

View shared research outputs
Researchain Logo
Decentralizing Knowledge